
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("
PROPOSED SECONDARY PLACING OF ORDINARY SHARES IN GLENVEAGH PLC
The Seller currently owns 113,897,285 ordinary shares, corresponding to approximately 21.5% of Glenveagh's entire issued share capital.
The price per Placing Share will be determined by way of an accelerated bookbuilding process to institutional investors. The Placing is subject to demand, price and prevailing market conditions. The Seller reserves the right to sell additional Placing Shares subject to demand. The bookbuilding period will commence with immediate effect following this announcement and may close at any time on short notice. The results of the Placing will be announced as soon as practicable after the closing of the bookbuilding process.
In the context of the Placing, any of the ordinary shares in Glenveagh held by the Seller which are not sold in the Placing will be subject to a 150-day lock-up undertaking (subject to certain customary exceptions).
Glenveagh has confirmed, in line with existing shareholder authorities and the terms of its current buyback programme announced to its shareholders on
ENQUIRIES
Davy (Joint Global Coordinator and Joint Bookrunner) +353 1 679 7788
Jefferies (Joint Global Coordinator and Joint Bookrunner) +44 (0)20 7029 8000
IMPORTANT NOTICE
This announcement is not for publication or distribution or release, directly or indirectly, in or into
This announcement does not constitute or form part of an offer for sale or solicitation of an offer to purchase or subscribe for securities in
In member states of the European Economic Area ("EEA") (each, a "Relevant Member State"), this announcement and any offer of Placing Shares if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of Article 2 of the Prospectus Regulation ("
In the
In
This press release is for information purposes only. No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision in connection with the Placing must be made on the basis of all publicly available information relating to Glenveagh and Glenveagh shares. Such information has not been independently verified. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness and such information shall in no way form the basis of, nor shall it be relied on in connection with, any contract to purchase or subscribe for any securities.
In connection with the Placing, the Joint Global Coordinators or any of their affiliates may take up a portion of the Placing Shares as a principal position and in that capacity may retain, purchase, sell, offer to sell for its own account such Placing Shares of Glenveagh or related investments in connection with the Placing or otherwise. Accordingly, references to the Placing Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by the Joint Global Coordinators and any of their affiliates acting as an investors for their own account. The Joint Global Coordinators do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.
This announcement does not purport to identify or suggest the risks (direct or indirect) which may be associated with an investment in Glenveagh or its shares.
The Joint Global Coordinators are acting for the Seller only in connection with the Placing and no one else and will not be responsible to anyone other than the Seller for providing the protections offered to clients nor for providing advice in relation to the Placing Shares or the Placing, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.
No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Seller, any Joint Global Coordinators or by any of their respective members, directors, officers, employees, agents or affiliates ("Relevant Persons") as to or in relation to the accuracy, completeness, correctness or sufficiency of this announcement, or any other written or oral information made available to any interested party or its advisers and any liability therefore is hereby expressly disclaimed.
The information contained in this announcement is subject to change without notice and may not contain all material information relating to the investment and transaction referred to herein. None of the Seller, the Joint Global Co-ordinators nor any of their respective group undertakings or Relevant Persons give any undertaking to provide the recipient with access to any additional information or to update this announcement or any additional information or to correct any inaccuracies in it which may become apparent, and it reserves the right, without giving reasons, at any time and in any respect to amend or terminate the proposals described herein.
Each Joint Global Coordinator is acting exclusively for the Seller and no one else in connection with the Placing, the contents of this Announcement or any other matters described in this Announcement. Neither Joint Global Coordinator will regard any other person as its client in relation to the Placing, the content of this Announcement or any other matters described in this Announcement and will not be responsible to anyone other than the Seller for providing the protections afforded to its clients or for providing advice to any other person in relation to the Placing, the content of this Announcement or any other matters referred to in, or contemplated by, this Announcement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the